#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13314	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2144	617.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	798	C	738	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13314	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2144	617.1	0	HET	.	.	.	A69G	.	69	69	A	299	299	A	746	A,G	364,325	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24658	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3474	707.2	0	.	n	.	0	T695C	SNP	695	695	T	962	962	C	730	C,T	681,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24658	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3474	707.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1604	1604	A	868	A	803	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24658	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3474	707.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2238	2238	C	814	C,A	759,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24658	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3474	707.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2312	2312	A	818	A,G	765,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24658	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3474	707.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2864	2864	C	736	C	676	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24658	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3474	707.2	0	HET	.	.	.	A412G	.	412	412	A	679	679	A	760	A,G	527,155	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1772	folP	855	855	100.0	folP.l15.c17.ctg.1	1517	116.5	1	SNP	p	R229S	1	.	.	685	687	AGC	983	985	AGC	158;154;155	A;G;C	148;146;144	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4476	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3415	130.7	1	SNP	p	S91F	1	.	.	271	273	TTC	655	657	TTC	150;149;148	T;T;C	138;140;138	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4476	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3415	130.7	1	SNP	p	G95N	0	.	.	283	285	GGC	667	669	GGC	148;150;151	G;G,T;C	140;136,1;139	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4476	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3415	130.7	1	SNP	p	D95G	1	.	.	283	285	GGC	667	669	GGC	148;150;151	G;G,T;C	140;136,1;139	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1438	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1414	101.4	1	SNP	p	G45D	0	.	.	133	135	GGC	466	468	GGC	176;171;173	G;G;C,T	162;158;160,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	740	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	878	83.4	0	.	n	.	0	A197.	DEL	197	197	A	508	508	A	182	A	165	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	153.3	1	SNP	p	D86N	0	.	.	256	258	GAC	646	648	GAC	187;185;187	G;A;C	170;167;172	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	153.3	1	SNP	p	R87I	0	.	.	259	261	CGT	649	651	CGT	187;187;189	C,A;G;T	172,1;174;172	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	153.3	1	SNP	p	S87R	1	.	.	259	261	CGT	649	651	CGT	187;187;189	C,A;G;T	172,1;174;172	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	153.3	1	SNP	p	R87W	0	.	.	259	261	CGT	649	651	CGT	187;187;189	C,A;G;T	172,1;174;172	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4704	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	153.3	1	SNP	p	S88P	0	.	.	262	264	TCC	652	654	TCC	186;187;187	T;C;C	170;172;173	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3854	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2711	141.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1572	1574	GGC	170;168;171	G;G;C	160;155;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1277	1279	GCA	198;199;202	G;C;A	170;169;175	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1280	1282	ATC	203;201;203	A;T;C	178;177;177	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1292	1294	GTG	204;204;201	G;T;G	181;178;177	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1292	1294	GTG	204;204;201	G;T;G	181;178;177	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1796	1798	ACC	195;194;195	A;C;C,T	166;173;177,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1850	1852	GCG	170;170;170	G;C;G	151;138;144	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1850	1852	GCG	170;170;170	G;C;G	151;138;144	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1973	1975	AGC	161;161;159	A;G;C	152;151;152	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1982	1984	GGC	160;159;161	G;G;C	147;147;147	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3674	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2406	152.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2000	2002	CCG	139;141;143	C,G;C;G	108,2;110;112	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4958	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3238	152.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1714	1716	CCG	182;179;179	C;C;G	152;164;154	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2126	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1621	129.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	483	483	C	149	C	138	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	365	367	GAA	231;233;231	G;A;A	211;214;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	653	655	GAT	205;204;206	G;A;T	191;189;191	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	776	778	TCA	197;197;196	T;C;A	177;178;178	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	0	.	p	.	0	F215L	NONSYN	643	645	TTT	896	898	CTT	181;183;186	C;T;T	168;174;176	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	905	907	GTC	182;184;186	G;T;C	174;177;178	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	0	.	p	.	0	F222S	NONSYN	664	666	TTT	917	919	TCT	195;197;197	T;C;T	185;186;187	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1235	1237	GCA	164;163;163	G;C;A	148;151;153	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	1	SNP	p	G120K	1	.	.	358	360	AAG	611	613	AAG	202;201;201	A;A;G	191;190;190	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	1	SNP	p	A121D	1	.	.	361	363	GAC	614	616	GAC	198;201;199	G;A;C	186;188;189	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2418	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1624	147.9	1	SNP	p	D121N	0	.	.	361	363	GAC	614	616	GAC	198;201;199	G;A;C	186;188;189	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9288	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4973	186.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	960	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	939	101.1	1	SNP	p	V57M	1	.	.	169	171	ATG	512	514	ATG	222;219;220	A;T;G	206;205;205	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
